Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTeam17 Regulatory News (TM17)

  • There is currently no data for TM17

Trading Update

25 Jan 2024 07:00

RNS Number : 8333A
Team17 Group PLC
25 January 2024
 

25 January 2024

 

 

Team17 Group plc

("Team17", the "Group" or the "Company")

 

Trading Update

 

Team17 Group plc, a global games label, creative partner, developer and publisher of independent ("indie") premium video games, educational entertainment ("edutainment") apps for children and working simulation games, provides the following trading update for the twelve months ended 31 December 2023 ("FY 2023" or the "Period").

All parts of the Group performed well over the key Black Friday and festive trading periods, in particular Team17 Games Label. As a result, as communicated in November, management continues to expect FY 2023 adjusted EBITDA to be at least £28.5m, which includes non-cash title impairments of up to £11.5m recognised in the Period.

Linked to the earlier Easter holiday dates this year, the Group expects to report results for FY 2023 on Tuesday 9 April, at which time management will provide additional insight into the Group's plans for 2024 and its broader strategic outlook.

Steve Bell, CEO of Team17, said:

"Having joined the business in September 2023, I am delighted to now formally take over as Group CEO, having spent the last four months fully immersing myself across the Group, with our people, portfolio of games and developers.

"I am pleased with how FY 2023 trading closed, finishing the year with positive momentum across the portfolio. I am extremely excited about the prospects for the Group in 2024 and beyond."

 

 

Enquiries: 

 

Team17 Group plc

Steve Bell, Chief Executive Officer

Mark Crawford, Chief Financial Officer

James Targett, Group Investor Relations Director

 

ir@team17.com

 

Houlihan Lokey UK Limited (Nominated Adviser)

Adrian Reed / Tim Richardson

 

+44 (0)20 7839 3355

Berenberg (Joint Corporate Broker)

Toby Flaux / Ben Wright / Marie Moy / Alix Mecklenburg-Solodkoff

 

+44 (0)20 3207 7800

Peel Hunt (Joint Corporate Broker)

Neil Patel / Paul Gillam / Kate Bannatyne

 

+44 (0)20 7418 8900

Vigo Consulting (Financial Public Relations)

Jeremy Garcia / Fiona Hetherington / Aisling Fitzgerald

team17@vigoconsulting.com

+44 (0)20 7390 0233

 

About Team17  

Team17 Group plc is a global provider of games entertainment to a broad audience. The Group now includes a games entertainment label and creative partner for indie developers, a leading developer of educational apps, targeting children under the age of eight, and a leading working simulation games developer and publisher. 

 

Visit www.team17.com for more info. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBIMMTMTJTTFI
Date   Source Headline
19th Sep 20237:00 amRNSHalf Year Results
12th Sep 20239:00 amRNSDirector/PDMR Shareholding
22nd Aug 20237:00 amRNSBoard Update
17th Aug 20234:46 pmRNSHolding(s) in Company
14th Aug 20239:00 amRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSNotice of Results & Trading Update
19th Jul 20237:00 amRNSDirectorate Changes
18th Jul 20232:15 pmRNSDirector/PDMR Shareholding
14th Jul 20237:00 amRNSAppointment of Joint Corporate Broker
12th Jul 20233:36 pmRNSDirector/PDMR Shareholding
22nd Jun 20232:01 pmRNSResult of AGM
16th Jun 20234:27 pmRNSHolding(s) in Company
14th Jun 20238:55 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNSAppointment of Group Chief Executive Officer
26th May 20237:01 amRNSBoard Update
26th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
25th May 20234:42 pmRNSHolding(s) in Company
15th May 202312:50 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSTeam17's astragon Acquires Independent Arts
13th Apr 20233:40 pmRNSIssue of Shares
12th Apr 20238:20 amRNSDirector/PDMR Shareholding
31st Mar 202311:15 amRNSDirector/PDMR Shareholding
28th Mar 20237:01 amRNSDirector Update
28th Mar 20237:00 amRNSUnaudited Final Results 2022
13th Mar 20234:49 pmRNSDirector/PDMR Shareholding
13th Mar 20239:05 amRNSNo Material Exposure to Silicon Valley Bank
2nd Mar 20237:00 amRNSNotice of Results & Analyst/Investor Presentations
13th Feb 20231:41 pmRNSDirector/PDMR Shareholding
31st Jan 20232:40 pmRNSHoldings in Company
19th Jan 20235:20 pmRNSHolding(s) in Company
18th Jan 20237:00 amRNSTrading Update
12th Jan 20239:04 amRNSDirector/PDMR Shareholding
10th Jan 20236:19 pmRNSHolding(s) in Company
9th Jan 20232:48 pmRNSTrading Update
13th Dec 20223:51 pmRNSDirector/PDMR Shareholding
17th Nov 20228:46 amRNSHolding(s) in Company
11th Nov 20225:13 pmRNSDirector/PDMR Shareholding
20th Oct 202212:11 pmRNSHolding(s) in Company
18th Oct 20221:42 pmRNSDirector/PDMR Shareholding
13th Sep 20224:32 pmRNSDirector/PDMR Shareholding
13th Sep 20227:00 amRNSHalf Year Results
5th Sep 20227:00 amRNSNotice of Results & Analyst/Investor presentations
12th Aug 20221:29 pmRNSDirector/PDMR Shareholding
18th Jul 20225:08 pmRNSHolding(s) in Company
15th Jul 20223:25 pmRNSHolding(s) in Company
14th Jul 20227:00 amRNSTrading Update
12th Jul 20223:56 pmRNSDirector/PDMR Shareholding
30th Jun 20223:58 pmRNSGrant of Options to Directors / PDMRs
29th Jun 20224:39 pmRNSResult of AGM
15th Jun 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.